Cape Investment Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.8K Buy
277
+87
+46% +$1.19K ﹤0.01% 1106
2026
Q2
$2.58K Buy
+190
New +$2.27K ﹤0.01% 1193
2026
Q1
– Sell
-111
Closed -$796 – 878
2025
Q4
$796 Buy
111
+67
+152% +$529 ﹤0.01% 1215
2025
Q3
$470 Sell
44
-86
-66% -$844 ﹤0.01% 782
2025
Q2
$1.26K Hold
130
– – ﹤0.01% 1008
2025
Q1
$1.94K Hold
130
– – ﹤0.01% 896
2024
Q4
$1.94K Buy
130
+44
+51% +$717 ﹤0.01% 883
2024
Q3
$1.64K Hold
86
– – ﹤0.01% 845
2024
Q2
$1.78K Hold
86
– – ﹤0.01% 796
2024
Q1
$1.61K Sell
86
-70
-45% -$1.2K ﹤0.01% 791
2023
Q4
$2.25K Buy
156
+7
+5% +$95 ﹤0.01% 909
2023
Q3
$2.58K Sell
149
-33
-18% -$688 ﹤0.01% 768
2023
Q2
$3.78K Sell
182
-29
-14% -$630 ﹤0.01% 701
2023
Q1
$4.96K Buy
+211
New +$5.67K ﹤0.01% 676

Other funds holding OGN

Cape Investment Advisory's OGN Position: Q3 2026 in Review

Cape Investment Advisory increased its Organon & Co (OGN) stake by 46% in Q3 2026, buying an estimated $1.19K and bringing the position to 277 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Cape Investment Advisory first reported a position in OGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.96K in Q1 2023. 37 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Cape Investment Advisory held 277 shares of Organon & Co worth $3.8K as of Q3 2026.
  • Cape Investment Advisory bought 87 Organon & Co shares in Q3 2026, an estimated $1.19K.
  • Organon & Co made up ﹤0.01% of Cape Investment Advisory's portfolio in Q3 2026, its #1106 holding.
  • Cape Investment Advisory first reported a position in Organon & Co in Q1 2023 and has held it in 14 quarters since.
  • Cape Investment Advisory's Organon & Co position peaked at $4.96K in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Cape Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.